RAGE 229
RAGE 229 is an orally active ctRAGE-DIAPH1 inhibitor. RAGE 229 can inhibit the intracellular RAGE signaling by inhibiting the interaction between the cytoplasmic tail of RAGE (ctRAGE) and Diaphanous-1 (DIAPH1) [1].
Product Specifications
CAS Number
2143072-85-7
UNSPSC
12352005
Target
Transmembrane Glycoprotein
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rage-229.html
Concentration
10mM
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
CC(NC1=CC=C(C2=NC3=CC(C#N)=CC=C3C(CN4CCOCC4)=C2)C=C1)=O
Molecular Formula
C23H22N4O2
Molecular Weight
386.45
References & Citations
[1]Michaele B Manigrasso, et al. Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice. Sci Transl Med. 2021 Nov 24;13 (621) :eabf7084.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2119182-01 0.1 mL
APC-Linked Monoclonal Antibody to Interleukin 18 (IL18)
Sign In for Pricing
View Details MBS2119182-02 0.2 mL
APC-Linked Monoclonal Antibody to Interleukin 18 (IL18)
Sign In for Pricing
View Details MBS2119182-03 0.5 mL
APC-Linked Monoclonal Antibody to Interleukin 18 (IL18)
Sign In for Pricing
View Details